FIELD: medicine.
SUBSTANCE: method involves introduction to a patient suffering a gastrointestinal stromal tumour (GIST) characterised by mutations chosen from a group KIT T670I, V454A and PDGFRA D842V of an effective amount of midostaurin. Use of the invention allows to treat the GIST with the mutations KIT T670I, V454A and PDGFRA D842V, causing imatinib resistance, due to inhibition of autophosphorylation of KIT kinase enabled by midostaurin action.
EFFECT: higher efficacy of the composition.
7 cl, 1 tbl, 2 ex
| Title |
Year |
Author |
Number |
| INHIBITORS OF KIT KINASE MUTANT FORM |
2004 |
- Bukhdunger Ehlizabet
- Fabbro Doriano
|
RU2405553C1 |
| INHIBITORS OF MUTANT FORM OF KINASE KIT |
2004 |
- Bukhdunger Ehlizabet
- Fabbro Doriano
|
RU2362562C2 |
| METHOD FOR OPTIMISING IMANITIB THERAPY OF PROLIFERATIVE DISEASES MEDIATED BY THYROSINE KINASE KIT RECEPTOR |
2009 |
- Jan'Fehn Van
- Ehlizabet Verle
|
RU2537223C2 |
| PAN-KIT KINASE INHIBITOR HAVING QUINOLINE STRUCTURE AND ITS USE |
2018 |
- Lyu, Tszin
- Lyu, Tsinsun
- Vu, Yun
- Van, Bejlej
- Tsi, Tszypin
- Tszou, Fenmin
- Lyu, Tsinvan
- Van, Venchao
- Chen, Chen
- Van, Tszyuntsze
- Van, Li
|
RU2789405C2 |
| COMPOSITIONS AND METHODS OF TREATING KIT- AND PDGFRα-MEDIATED DISEASES |
2020 |
- Kim, Dzhozef, L.
- Dajnin, Tomas, A.
- Guzi, Timoti
|
RU2817354C2 |
| COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND IMANITIB DERIVATIVES FOR TREATMENT OR PREVENTION OF PROLIFERATIVE DISEASES |
2006 |
- Olland Lila
- Manli Pol U.
- Mestan Jurgen
|
RU2430727C2 |
| METHOD FOR OPTIMIZING TREATMENT OF STROMAL TUMORS OF GASTROINTESTINAL TRACT |
2020 |
- Kogoniya Lali Mikhajlovna
- Adlejba Sariya Temurovna
- Gurevich Larisa Evseevna
|
RU2753391C1 |
| PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR NEUROFIBROMATOSIS |
2006 |
|
RU2450814C2 |
| COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS |
2006 |
|
RU2429848C2 |
| COMBINATION OF INHIBITOR FGFR AND INHIBITOR IGF1R |
2015 |
- Jovcheva Eleonora
- Perera Timothy Pietro Suren
|
RU2715893C2 |
